Dec 19, 2022LIfT BioSciences investors increase investment in LIfT and Johnson and Johnson welcomes LIfT into JLLondon, 19 December 2022 – LIfT BioSciences is pleased to announce that it’s lead investor, Starbloom Capital, has provided further...
Nov 7, 2022Alex Blyth's Interview about how LIfT came to be, and why we need to move on from mouse modelsThe Business of Biotech interviews serial inventor and entrepreneur Alex Blyth who had long held interests in health and science, but...
Oct 21, 2022LIfT at The Rejuvenation SummitLIfT BioSciences presented at Forever Healthy Foundation's Rejuvenation Summit In Berlin. Alex Blyth, LIfT's CEO, presented on the links...